Brainstorm’s Stem Cell Based Drug NurOwn Gets FDA Fast Track Approval

BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the US Food and Drug Administration has designated NurOwn as a Fast Track More...